J Pharma

J Pharma is a Clinical stage biopharmaceutical company with a focus on Solute Carrier (SLC) transporters. Founded in 2005 in Japan, J-Pharma has been conducting unique drug developments under the leadership of Hitoshi Endou, MD., Ph.D., a former professor of Kyorin University Faculty of Medicine. The company's recent efforts have been centered around the clinical development of original inhibitors of L-type amino acid transporter 1 (“LAT1”) for treating advanced cancer patients who have not benefited from standard chemotherapy. In its Series D funding round, J-Pharma secured a substantial investment of ¥500.00M from Eight Roads Ventures and F-Prime Capital in January 7, 2021. J-Pharma's unique focus in the biotechnology sector and its successful partnerships with prominent investors position it as a notable player in the pharmaceutical industry.